MedTrace Logo

Efficacy of Topical Morphine in the Treatment of Severe Local Pain of Chronic Wounds

NCT02028923 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2016-11-21

No results posted yet for this study

Summary

This phase III study aims to show that topical morphine low doses treats localized pain in chronic wounds, intense and rebellious to systemic analgesics included or not opioids.

Conditions

  • Local Pain
  • Chronic Wounds

Interventions

DRUG

Morphine gel

Topical

OTHER

Neutral gel

Topical

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    collaborator OTHER

  • Hôpital Louis Mourier

    collaborator OTHER

  • Institut Curie

    lead OTHER

Principal Investigators

  • Valerie LAURENT, MD · Institut Curie - Hôpital René Huguenin

  • Audrey Hurgon, MD · Institut Curie Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02028923 on ClinicalTrials.gov